Turkish Journal of Gastroenterology
Liver - Original Article

Bone Mineral Density Screening and the Frequency of Osteopenia/Osteoporosis in Turkish Adult Patients With Celiac Disease

1.

Department of Gastroenterology, Health Sciences Unıversity, Ümraniye Training and Research Hospital, İstanbul, Turkey

2.

Department of Internal Medicine, Health Sciences Unıversity, Ümraniye Training and Research Hospital, İstanbul, Turkey

Turk J Gastroenterol 2021; 32: 600-607
DOI: 10.5152/tjg.2021.20313
Read: 1095 Downloads: 346 Published: 01 July 2021

Background: The aim of this study was to evaluate the prevalence of osteopenia and osteoporosis in adult patients with celiac disease (CD) at diagnosis and/or in the follow-up after a gluten-free diet (GFD).

Methods: Adult patients diagnosed with CD were retrospectively screened through follow-up records and computer databases. Patients assessed by dual-energy X-ray absorptiometry (DEXA) at diagnosis and/or in the follow-up after a GFD were included in the study.

Results: One hundred patients who underwent a DEXA scan at least once after diagnosis or after being on a GFD were included in the study. The mean age of the patients at diagnosis was 34.61 ± 10.3 years, and 84% of the patients (n = 84) were female. At the time of diagnosis (n = 46), the prevalence of osteopenia and osteoporosis was 67.3% and 15.2%, respectively, at the lumbar spine, and 43.4% and 10.8%, respectively, at the femur. After a GFD (n = 78), the prevalence of osteopenia and osteoporosis was 61.5% and 8.9%, respectively, at the lumbar spine, and 37.1% and 2.5%, respectively, at the femur.

Conclusion: The prevalence of CD patients with low bone mineral density (BMD) is high after diagnosis and in the follow-up after a GFD. It is important for all patients with CD to undergo a DEXA scan to determine the follow-up and/or treatment characteristics.

Cite this article as: Sayar S, Aykut H, Kaya Ö, et al. Bone mineral density screening and the frequency of osteopenia/osteoporosis in Turkish adult patients with Celiac disease. Turk J Gastroenterol. 2021; 32(7): 600-607.

Files
EISSN 2148-5607